IMP
Process View
cellular response to increased oxygen levels
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting an increase in the level of oxygen.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cellular response to increased oxygen levels"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 1.000 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 1.000 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 1.000 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 1.000 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 1.000 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.999 | Human | |
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.997 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.996 | Human | |
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.932 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.875 | ||
| CAV2 | caveolin 2 | 0.696 | Human | |
| TRADD | TNFRSF1A-associated via death domain | 0.682 | ||
| BID | BH3 interacting domain death agonist | 0.606 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.592 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.384 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.352 | Human | |
| AR | androgen receptor | 0.313 | ||
| DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | 0.277 | ||
| CREBBP | CREB binding protein | 0.261 | ||
| PTPRF | protein tyrosine phosphatase, receptor type, F | 0.130 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.116 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.102 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.084 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.066 | ||
| PTEN | phosphatase and tensin homolog | 0.063 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.062 | ||
| F2R | coagulation factor II (thrombin) receptor | 0.055 | ||
| DAXX | death-domain associated protein | 0.054 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.054 | ||
| PRDX1 | peroxiredoxin 1 | 0.049 | ||
| FOXO3 | forkhead box O3 | 0.049 | Human | |
| POMP | proteasome maturation protein | 0.049 | ||
| PRKCDBP | protein kinase C, delta binding protein | 0.046 | ||
| FOXO1 | forkhead box O1 | 0.045 | ||
| UHRF1 | ubiquitin-like with PHD and ring finger domains 1 | 0.038 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.035 | ||
| FHL2 | four and a half LIM domains 2 | 0.030 | ||
| SEC61G | Sec61 gamma subunit | 0.029 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.026 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.025 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.025 | ||
| EGR3 | early growth response 3 | 0.024 | ||
| GJA1 | gap junction protein, alpha 1, 43kDa | 0.024 | ||
| DYNLT1 | dynein, light chain, Tctex-type 1 | 0.023 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.023 | ||
| SDPR | serum deprivation response | 0.022 | ||
| ESR1 | estrogen receptor 1 | 0.022 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.021 | ||
| PTRF | polymerase I and transcript release factor | 0.021 | ||
| MYL6 | myosin, light chain 6, alkali, smooth muscle and non-muscle | 0.021 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.019 | ||
| EDNRB | endothelin receptor type B | 0.018 | ||
| GABARAPL2 | GABA(A) receptor-associated protein-like 2 | 0.017 | ||
| CD59 | CD59 molecule, complement regulatory protein | 0.016 | ||
| EGR2 | early growth response 2 | 0.015 | ||
| NOL3 | nucleolar protein 3 (apoptosis repressor with CARD domain) | 0.015 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.015 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.014 | ||
| LDLR | low density lipoprotein receptor | 0.014 | ||
| EGFR | epidermal growth factor receptor | 0.014 | ||
| IER2 | immediate early response 2 | 0.014 | ||
| TXNRD1 | thioredoxin reductase 1 | 0.013 | Rat | |
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.013 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.013 | ||
| PROCR | protein C receptor, endothelial | 0.013 | ||
| GABARAP | GABA(A) receptor-associated protein | 0.012 | ||
| ESRRG | estrogen-related receptor gamma | 0.012 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.011 | ||
| IRF2 | interferon regulatory factor 2 | 0.011 | ||
| TUBB6 | tubulin, beta 6 | 0.011 | ||
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.011 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.011 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.011 | ||
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.011 | ||
| DUSP23 | dual specificity phosphatase 23 | 0.011 |